research in mice “suggests a drug originally developed to treat diabetes significantly reverses memory loss and brain degeneration in mice with a rodent version of Alzheimer’s disease.” The medication “is called a triple receptor drug and according to the study, combines GLP-1, GIP and glucagon, three biological molecules known as ‘growth factors.’” The findings were published online Jan. 1 in the journal Brain Research. Fierce Biotech (12/31, Weintraub) also covered the story.
http://www.newsweek.com/alzheimers-diabetes-new-medication-drug-development-767510
No comments:
Post a Comment